The European Commission/Horizon 2020

GlucoSet has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 822653. The project’s aim is to develop GlucoSet’s sensor technology and test it in patients, for commercial launch of the technology.

GlucoSet is also supported by the instruments Cross4Health and Innolabs.


The Research Council of Norway

GlucoSet is supported by The Research Council of Norway through grants like NANO2021 and SkatteFUNN, for research on the company’s sensor technology.